Serina Therapeutics, Inc. Intangible Assets, Net (Excluding Goodwill)
Serina Therapeutics, Inc. (SER) had Intangible Assets, Net (Excluding Goodwill) of $509.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2024-11-12
- 2024-09-30: Intangible Assets, Net (Excluding Goodwill) $509.00K.
- 2024-06-30: Intangible Assets, Net (Excluding Goodwill) $541.00K.
- 2024-03-31: Intangible Assets, Net (Excluding Goodwill) $574.00K.
- 2023-12-31: Intangible Assets, Net (Excluding Goodwill) $0.00; Intangible Assets, Net (Excluding Goodwill) as first filed $607.00K.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2024-09-30 | $509.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $541.00K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $574.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-12 | $607.00K 10-K · filed 2024-03-22 |
| 2023-09-30 | $640.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $673.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $705.00K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $738.00K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $771.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $804.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $837.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $870.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $902.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $935.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $968.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.59M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $1.73M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.87M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $2.01M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $2.15M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $2.29M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $2.43M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.57M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.71M 10-K/A · filed 2020-03-31 | |
| 2017-12-31 | $1.87M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |